Evaluation of Clinical and Laboratory Parameters Used in the Identification of Index Cases for Genetic Screening of Familial Hypercholesterolemia in Brazil

Atherosclerosis - Netherlands
doi 10.1016/j.atherosclerosis.2017.06.917
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Clinical Evaluation of Evolocumab for the Treatment of Homozygous Familial Hypercholesterolemia in Chinese Patients

Therapeutics and Clinical Risk Management
2019English

Mutational Screening in the LDLR Gene Among Patients Presenting Familial Hypercholesterolemia in the Southeast of Brazil

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2017English

Evaluation of the Role of STAP1 in Familial Hypercholesterolemia

Scientific Reports
Multidisciplinary
2019English

Systematic Family Screening for Familial Hypercholesterolemia in Iceland

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2002English

Cardio-Ankle Vascular Index in Heterozygous Familial Hypercholesterolemia

Journal of Atherosclerosis and Thrombosis
BiochemistryInternal MedicineCardiovascular MedicineCardiology
2012English

Long-Term Compliance With Lipid-Lowering Medication After Genetic Screening for Familial Hypercholesterolemia

Archives of Internal Medicine
2003English

Genetic Determinants of Plasma HDL-cholesterol Levels in Familial Hypercholesterolemia

European Journal of Human Genetics
Genetics
2005English

Finding Missed Cases of Familial Hypercholesterolemia in Health Systems Using Machine Learning

npj Digital Medicine
2019English

Visual Hemolysis Index for Routine Clinical Chemistry Laboratory Parameters

International Journal of Clinical Biochemistry and Research
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy